{"product_id":"neurodegenerative-diseases-drugs-market-set-to-reach-usd-77-76-billion-by-2030","title":"Neurodegenerative Diseases Drugs Market Set to reach USD 77.76 billion by 2030","description":"\u003cp class=\"MsoNormal\"\u003eAccording to the study by Next Move Strategy Consulting, the global \u003ca href=\"https:\/\/www.nextmsc.com\/report\/neurodegenerative-diseases-drugs-market\"\u003e\u003cstrong\u003eNeurodegenerative Diseases Drugs Market\u003c\/strong\u003e\u003c\/a\u003e size is predicted to reach USD 77.76 billion with a CAGR of 7.2% till 2030.\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003eThe major driving factor of the growth of the neurodegenerative diseases drugs market is the increasing prevalence of neurodegenerative disorders, such as dementia, spinal muscular atrophy, and Friedreich ataxia around the globe. \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003eThe North American region holds the lion's share in the neurodegenerative disease drugs market trends, and is expected to continue to dominate the market during the forecast period. \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003eRequest for a FREE Sample PDF\u003c\/b\u003e : \u003ca href=\"https:\/\/www.nextmsc.com\/neurodegenerative-diseases-drugs-market\/request-sample\"\u003ehttps:\/\/www.nextmsc.com\/neurodegenerative-diseases-drugs-market\/request-sample\u003c\/a\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e \u003c\/p\u003e","brand":"Next Move Strategy Consulting","offers":[{"title":"Default Title","offer_id":49773972062484,"sku":"","price":3975.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0915\/3819\/4708\/files\/NeurodegenerativeDiseasesDrugsMarket.png?v=1732005574","url":"https:\/\/nextmovestrategyconsulting.myshopify.com\/products\/neurodegenerative-diseases-drugs-market-set-to-reach-usd-77-76-billion-by-2030","provider":"Next Move Strategy Consulting","version":"1.0","type":"link"}